Myles Wolf

Entity
Individual
Business address
C/O Akebia Therapeutics, Inc., 245 First Street, 02142 Cambridge, MA
Insider ownership signature
/s / Carolyn Rucci, attorney-in-fact for Myles Wolf
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Myles Wolf has filed 7 SEC EDGAR filings since 4/7/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT Jun 11, 2025 Jun 10, 2025 001-36352
4 Open Document Open Filing PRIMARY DOCUMENT Jun 10, 2024 Jun 6, 2024 001-36352
4 Open Document Open Filing PRIMARY DOCUMENT Jun 8, 2023 Jun 6, 2023 001-36352
4 Open Document Open Filing PRIMARY DOCUMENT Jun 9, 2022 Jun 8, 2022 001-36352
4 Open Document Open Filing PRIMARY DOCUMENT Jun 3, 2021 Jun 2, 2021 001-36352
4 Open Document Open Filing PRIMARY DOCUMENT Apr 7, 2020 Apr 6, 2020 001-36352
3 Open Document Open Filing PRIMARY DOCUMENT Apr 7, 2020 Apr 6, 2020 001-36352